Mira Pharmaceuticals Inc (MIRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 1,731 | 1,768 | 3,056 | 3,160 | 970 |
| Operating Income | -1,731 | -1,768 | -3,056 | -3,160 | -970 |
| Interest Expense | -39 | -50 | 2,731 | 428 | 296 |
| Pre-tax Income | -1,691 | -1,718 | -5,787 | -3,588 | -1,266 |
| Net Income Continuous | -1,691 | -1,718 | -5,787 | -3,588 | -1,266 |
| Net Income | $-1,691 | $-1,718 | $-5,787 | $-3,588 | $-1,266 |
| EPS Basic Total Ops | -0.11 | -0.15 | -0.39 | -0.26 | -0.10 |
| EPS Basic Continuous Ops | -0.11 | -0.12 | -0.43 | -0.26 | -0.10 |
| EPS Diluted Total Ops | -0.11 | -0.15 | -0.39 | -0.26 | -0.10 |
| EPS Diluted Continuous Ops | -0.11 | -0.12 | -0.43 | -0.26 | -0.10 |
| EPS Diluted Before Non-Recurring Items | -0.11 | -0.12 | -0.19 | N/A | N/A |
| EBITDA(a) | $-1,731 | $-1,768 | $-3,056 | $-2,721 | $-970 |